| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.795 | 0.023 | 0.795 | Beta lactamase inhibitor | 0.642 0.047 DBMET00758 | ||
| 0.766 | 0.005 | 0.797 | Antibacterial | 0.797 0.004 DBMET00758 0.337 0.109 DBMET00983 | DBMET00758 | |
| 0.632 | 0.004 | 0.676 | Chelator | 0.676 0.003 DBMET00758 0.183 0.028 DBMET00983 | DBMET00758 | |
| 0.581 | 0.002 | 0.581 | Cell wall synthesis inhibitor | 0.569 0.002 DBMET00758 0.254 0.015 DBMET00983 | ||
| 0.503 | 0.003 | 0.503 | Antibacterial (Helicobacter pylori) | 0.271 0.009 DBMET00758 | ||
| 0.487 | 0.03 | 0.487 | Streptokinase A inhibitor | 0.476 0.032 DBMET00758 | ||
| 0.438 | 0.011 | 0.448 | Diuretic | 0.448 0.01 DBMET00758 0.131 0.094 DBMET00983 | DBMET00758 | |
| 0.31 | 0 | 0.667 | Antibiotic Penicillin-like | 0.667 0 DBMET00758 0.004 0.001 DBMET00983 | DBMET00758 | |
| 0.273 | 0.004 | 0.273 | Leukocyte elastase inhibitor | 0.208 0.004 DBMET00758 | ||
| 0.215 | 0.005 | 0.215 | Lipase inhibitor | 0.208 0.005 DBMET00758 | ||
| 0.262 | 0.066 | 0.262 | Gastrin inhibitor | 0.248 0.082 DBMET00758 0.235 0.098 DBMET00983 | ||
| 0.322 | 0.141 | 0.393 | 5 Hydroxytryptamine release inhibitor | 0.326 0.137 DBMET00758 0.393 0.082 DBMET00983 | DBMET00983 | |
| 0.321 | 0.14 | 0.321 | Calcium channel L-type activator | 0.288 0.168 DBMET00983 | ||
| 0.267 | 0.101 | 0.423 | Interleukin 2 agonist | 0.292 0.079 DBMET00758 0.423 0.021 DBMET00983 | DBMET00983 | |
| 0.197 | 0.035 | 0.235 | Alpha-N-acetylglucosaminidase inhibitor | 0.235 0.026 DBMET00758 0.153 0.053 DBMET00983 | DBMET00758 | |
| 0.145 | 0.005 | 0.184 | Elastase inhibitor | 0.184 0.004 DBMET00758 | DBMET00758 | |
| 0.151 | 0.016 | 0.174 | Transcription factor NF kappa B stimulant | 0.174 0.012 DBMET00758 | DBMET00758 | |
| 0.222 | 0.093 | 0.351 | DNA synthesis inhibitor | 0.351 0.03 DBMET00758 | DBMET00758 | |
| 0.24 | 0.117 | 0.24 | Ca(v)3.3 blocker | 0.218 0.155 DBMET00983 | ||
| 0.097 | 0.009 | 0.129 | Angiotensin-converting enzyme inhibitor | 0.129 0.006 DBMET00758 0.072 0.018 DBMET00983 | DBMET00758 | |
| 0.123 | 0.038 | 0.13 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.13 0.034 DBMET00758 0.102 0.052 DBMET00983 | DBMET00758 | |
| 0.169 | 0.087 | 0.169 | DNA methyltransferase I inhibitor | 0.157 0.097 DBMET00758 | ||
| 0.083 | 0.003 | 0.104 | Elastase 2A inhibitor | 0.104 0.003 DBMET00758 | DBMET00758 | |
| 0.083 | 0.003 | 0.104 | Elastase 2 inhibitor | 0.104 0.003 DBMET00758 | DBMET00758 | |
| 0.12 | 0.047 | 0.198 | Protease inhibitor | 0.12 0.048 DBMET00758 0.198 0.015 DBMET00983 | DBMET00983 | |
| 0.123 | 0.051 | 0.163 | Aminopeptidase B inhibitor | 0.163 0.032 DBMET00758 0.146 0.039 DBMET00983 | DBMET00758 | |
| 0.1 | 0.029 | 0.114 | Thioredoxin reductase inhibitor | 0.114 0.019 DBMET00758 | DBMET00758 | |
| 0.166 | 0.104 | 0.166 | DNA methylase inhibitor | 0.147 0.12 DBMET00758 | ||
| 0.161 | 0.099 | 0.297 | Hepatoprotectant | 0.212 0.058 DBMET00758 0.297 0.03 DBMET00983 | DBMET00983 | |
| 0.097 | 0.036 | 0.122 | Somatostatin 1 agonist | 0.122 0.023 DBMET00758 0.077 0.055 DBMET00983 | DBMET00758 | |
| 0.079 | 0.02 | 0.096 | Protein 50S ribosomal subunit inhibitor | 0.096 0.014 DBMET00758 | DBMET00758 | |
| 0.115 | 0.059 | 0.153 | Mucolytic | 0.153 0.031 DBMET00758 0.145 0.035 DBMET00983 | DBMET00758 | |
| 0.08 | 0.025 | 0.11 | Neuraminidase inhibitor | 0.11 0.012 DBMET00758 0.067 0.036 DBMET00983 | DBMET00758 | |
| 0.153 | 0.101 | 0.19 | Phospholipase C inhibitor | 0.19 0.051 DBMET00758 | DBMET00758 | |
| 0.145 | 0.108 | 0.145 | Amyloid beta precursor protein antagonist | |||
| 0.04 | 0.005 | 0.06 | Human T-cell leukemia virus type I protease inhibitor | 0.059 0.004 DBMET00758 0.06 0.004 DBMET00983 | DBMET00983 | |
| 0.03 | 0.002 | 0.035 | Antibiotic Tetracycline-like | 0.035 0.002 DBMET00758 | DBMET00758 | |
| 0.036 | 0.009 | 0.036 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.017 DBMET00758 | ||
| 0.049 | 0.023 | 0.049 | Baculoviral IAP repeat-containing protein inhibitor | 0.045 0.035 DBMET00758 | ||
| 0.041 | 0.016 | 0.069 | Glutamate (mGluR8) antagonist | 0.054 0.007 DBMET00758 0.069 0.004 DBMET00983 | DBMET00983 | |
| 0.059 | 0.035 | 0.427 | Maillard reaction inhibitor | 0.076 0.026 DBMET00758 0.427 0.002 DBMET00983 | DBMET00983 | |
| 0.065 | 0.044 | 0.081 | Neuraminidase (influenza) inhibitor | 0.081 0.025 DBMET00758 | DBMET00758 | |
| 0.046 | 0.026 | 0.899 | HIV-1 protease inhibitor | 0.041 0.034 DBMET00758 0.899 0.002 DBMET00983 | DBMET00983 | |
| 0.03 | 0.012 | 0.03 | Neutral endopeptidase inhibitor | 0.023 0.014 DBMET00758 | ||
| 0.19 | 0.173 | 0.211 | Insulysin inhibitor | 0.194 0.166 DBMET00758 0.211 0.141 DBMET00983 | DBMET00983 | |
| 0.046 | 0.03 | 0.058 | Neuraminidase (Influenza A) inhibitor | 0.058 0.014 DBMET00758 0.046 0.03 DBMET00983 | DBMET00758 | |
| 0.166 | 0.155 | 0.166 | Peptidyltransferase inhibitor | |||
| 0.051 | 0.047 | 0.072 | DNA helicase inhibitor | 0.072 0.015 DBMET00983 | DBMET00983 | |
| 0.052 | 0.048 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.037 DBMET00758 | DBMET00758 | |
| 0.03 | 0.035 | 0.037 | Somatostatin 1 antagonist | 0.037 0.028 DBMET00758 | DBMET00758 | |
| 0.018 | 0.025 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.012 DBMET00758 | DBMET00758 | |
| 0.081 | 0.095 | 0.117 | Expectorant | 0.117 0.053 DBMET00758 0.106 0.063 DBMET00983 | DBMET00758 | |
| 0.008 | 0.024 | 0.029 | Integrin alpha4beta1 antagonist | 0.029 0.007 DBMET00983 | DBMET00983 | |
| 0.014 | 0.032 | 0.064 | Integrin alpha4 antagonist | 0.064 0.009 DBMET00983 | DBMET00983 | |
| 0.018 | 0.037 | 0.035 | Urotensin II agonist | 0.035 0.012 DBMET00983 | DBMET00983 | |
| 0.091 | 0.111 | 0.208 | Cell adhesion inhibitor | 0.208 0.023 DBMET00983 | DBMET00983 | |
| 0.044 | 0.067 | 0.1 | NMDA receptor glycine site agonist | 0.058 0.048 DBMET00758 0.1 0.016 DBMET00983 | DBMET00983 | |
| 0.078 | 0.101 | 0.121 | Ferrochelatase inhibitor | 0.121 0.053 DBMET00758 | DBMET00758 | |
| 0.01 | 0.041 | 0.032 | VLA-4 antagonist | 0.032 0.017 DBMET00983 | DBMET00983 | |
| 0.046 | 0.081 | 0.104 | NMDA receptor agonist | 0.059 0.048 DBMET00758 0.104 0.018 DBMET00983 | DBMET00983 | |
| 0.133 | 0.171 | 0.199 | Immunostimulant | 0.199 0.121 DBMET00758 | DBMET00758 | |
| 0.035 | 0.075 | 0.212 | Opioid delta receptor antagonist | 0.212 0.01 DBMET00983 | DBMET00983 | |
| 0.009 | 0.05 | 0.029 | Kainate receptor 5 antagonist | 0.029 0.01 DBMET00983 | DBMET00983 | |
| 0.012 | 0.054 | 0.039 | Kainate receptor 4 antagonist | 0.039 0.009 DBMET00983 | DBMET00983 | |
| 0.009 | 0.054 | 0.02 | Kainate receptor 3 antagonist | 0.02 0.009 DBMET00983 | DBMET00983 | |
| 0.054 | 0.099 | 0.095 | GABA aminotransferase inhibitor | 0.095 0.031 DBMET00758 | DBMET00758 | |
| 0.03 | 0.081 | 0.045 | Kainate receptor agonist | 0.045 0.02 DBMET00758 0.043 0.025 DBMET00983 | DBMET00758 | |
| 0.047 | 0.102 | 0.065 | Aminopeptidase I inhibitor | 0.065 0.061 DBMET00983 | DBMET00983 | |
| 0.016 | 0.077 | 0.087 | Integrin antagonist | 0.087 0.018 DBMET00983 | DBMET00983 | |
| 0.168 | 0.23 | 0.199 | 5 Hydroxytryptamine uptake stimulant | 0.199 0.154 DBMET00983 | DBMET00983 | |
| 0.164 | 0.229 | 0.255 | Antithrombotic | 0.209 0.166 DBMET00758 0.255 0.122 DBMET00983 | DBMET00983 | |
| 0.049 | 0.114 | 0.075 | Metalloproteinase-2 inhibitor | 0.075 0.058 DBMET00983 | DBMET00983 | |
| 0.064 | 0.132 | 0.251 | GABA C receptor agonist | 0.251 0.013 DBMET00758 0.089 0.08 DBMET00983 | DBMET00758 | |
| 0.049 | 0.122 | 0.086 | Glutamate (mGluR6) antagonist | 0.086 0.018 DBMET00758 0.072 0.035 DBMET00983 | DBMET00758 | |
| 0.033 | 0.108 | 0.187 | Opioid mu receptor antagonist | 0.187 0.011 DBMET00983 | DBMET00983 | |
| 0.044 | 0.119 | 0.14 | Analgesic, opioid | 0.14 0.017 DBMET00983 | DBMET00983 | |
| 0.022 | 0.099 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.027 DBMET00758 | DBMET00758 | |
| 0.021 | 0.098 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.015 DBMET00758 | DBMET00758 | |
| 0.052 | 0.131 | 0.208 | Opioid antagonist | 0.208 0.013 DBMET00983 | DBMET00983 | |
| 0.01 | 0.093 | 0.034 | AMPA 2 receptor antagonist | 0.034 0.017 DBMET00983 | DBMET00983 | |
| 0.02 | 0.117 | 0.048 | Metalloproteinase-3 inhibitor | 0.048 0.035 DBMET00983 | DBMET00983 | |
| 0.051 | 0.149 | 0.13 | Cell adhesion molecule inhibitor | 0.13 0.02 DBMET00983 | DBMET00983 | |
| 0.027 | 0.126 | 0.066 | Biliverdin reductase inhibitor | 0.066 0.035 DBMET00758 | DBMET00758 | |
| 0.025 | 0.137 | 0.054 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.039 DBMET00983 | DBMET00983 | |
| 0.009 | 0.122 | 0.034 | Kainate receptor 2 antagonist | 0.034 0.026 DBMET00983 | DBMET00983 | |
| 0.02 | 0.133 | 0.041 | AMPA 4 receptor antagonist | 0.041 0.024 DBMET00983 | DBMET00983 | |
| 0.008 | 0.121 | 0.082 | GP IIb/IIIa receptor antagonist | 0.082 0.021 DBMET00983 | DBMET00983 | |
| 0.134 | 0.252 | 0.188 | Cholesterol antagonist | 0.188 0.175 DBMET00758 0.188 0.176 DBMET00983 | DBMET00983 | |
| 0.019 | 0.138 | 0.069 | Neutrophil collagenase inhibitor | 0.069 0.041 DBMET00983 | DBMET00983 | |
| 0.049 | 0.176 | 0.102 | Topoisomerase II inhibitor | 0.102 0.084 DBMET00758 | DBMET00758 | |
| 0.051 | 0.183 | 0.082 | Triose-phosphate isomerase inhibitor | 0.082 0.072 DBMET00758 | DBMET00758 | |
| 0.01 | 0.155 | 0.034 | Opioid delta receptor agonist | 0.034 0.027 DBMET00983 | DBMET00983 | |
| 0.037 | 0.183 | 0.077 | Glutamate dehydrogenase inhibitor | 0.077 0.047 DBMET00758 | DBMET00758 | |
| 0.11 | 0.268 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.146 0.054 DBMET00758 | DBMET00758 | |
| 0.082 | 0.244 | 0.211 | Interleukin agonist | 0.211 0.11 DBMET00983 | DBMET00983 | |
| 0.137 | 0.3 | 0.213 | Tyrosine 3 hydroxylase inhibitor | 0.213 0.113 DBMET00983 | DBMET00983 | |
| 0.016 | 0.187 | 0.054 | Acyl-CoA dehydrogenase inhibitor | 0.054 0.039 DBMET00758 | DBMET00758 | |
| 0.085 | 0.28 | 0.298 | Vasodilator | 0.298 0.049 DBMET00983 | DBMET00983 | |
| 0.035 | 0.243 | 0.066 | Glycine receptor agonist | 0.066 0.063 DBMET00758 | DBMET00758 | |
| 0.045 | 0.261 | 0.086 | Electrolyte absorption antagonist | 0.086 0.081 DBMET00758 | DBMET00758 | |
| 0.039 | 0.281 | 0.094 | GABA C receptor rho-1 antagonist | 0.094 0.07 DBMET00758 | DBMET00758 | |
| 0.023 | 0.269 | 0.067 | Prostaglandin F2 alpha antagonist | 0.067 0.036 DBMET00983 | DBMET00983 | |
| 0.013 | 0.263 | 0.063 | Phosphofructokinase-1 inhibitor | 0.063 0.054 DBMET00758 | DBMET00758 | |
| 0.039 | 0.31 | 0.091 | NADH dehydrogenase inhibitor | 0.091 0.055 DBMET00758 | DBMET00758 | |
| 0.049 | 0.323 | 0.103 | Adenylate kinase inhibitor | 0.103 0.063 DBMET00758 | DBMET00758 | |
| 0.011 | 0.34 | 0.054 | Carbamoyl phosphate synthetase inhibitor | 0.054 0.05 DBMET00758 | DBMET00758 | |
| 0.08 | 0.445 | 0.18 | RNA-directed DNA polymerase inhibitor | 0.18 0.133 DBMET00758 | DBMET00758 | |
| 0.023 | 0.389 | 0.095 | GABA C receptor antagonist | 0.095 0.087 DBMET00758 | DBMET00758 | |
| 0.014 | 0.654 | 0.169 | Platelet antagonist | 0.169 0.126 DBMET00983 | DBMET00983 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |